Emerald Advisors, LLC Bristol Myers Squibb CO Transaction History
Emerald Advisors, LLC
- $774 Million
- Q2 2025
A detailed history of Emerald Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Emerald Advisors, LLC holds 19,293 shares of BMY stock, worth $898,089. This represents 0.12% of its overall portfolio holdings.
Number of Shares
19,293
Previous 16,298
18.38%
Holding current value
$898,089
Previous $994,000
10.16%
% of portfolio
0.12%
Previous 0.13%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,665Shares Held
1.6BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...